AMLX — AMYLYX PHARMACEUTICALS INC

Ownership history in Commodore Capital LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in AMYLYX PHARMACEUTICALS INC (AMLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.54% (2025 Q4)
Avg. % of fund
3.62%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 5,650,000 +1,574,522 +38.6% 4.54% $68.3M $12.08
2025 Q3 INITIATED 4,075,478 — — 2.70% $55.4M $13.59
% of Fund (quarterly)    AMLX price (monthly, adj. close)

Other funds also holding AMLX

As of 2025 Q4 — sorted by position size

Saturn V Capital Management LP 3Y 9.97% GREAT POINT PARTNERS LLC 3Y 7Y 6.85% Almitas Capital LLC 3Y 7Y 5.65% First Light Asset Management, LLC 3Y 7Y 3.1% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 2.73% TCG Crossover Management, LLC 3Y 2.5% Aldebaran Capital, LLC 3Y 2.15% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.78% STEMPOINT CAPITAL LP 1.17% Patient Square Capital LP 3Y 0.91%
← Back to Commodore Capital LP Holdings